Preeti Urology & Kidney Hospital Profile
Key Indicators
- Authorised Capital ₹ 5.60 M
as on 24-10-2024
- Paid Up Capital ₹ 5.07 M
as on 24-10-2024
- Company Age 13 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.31 Cr
as on 24-10-2024
- Revenue 6.20%
(FY 2023)
- Profit 17.35%
(FY 2023)
- Ebitda 3.61%
(FY 2023)
- Net Worth 24.55%
(FY 2023)
- Total Assets 7.19%
(FY 2023)
About Preeti Urology & Kidney Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.60 M and a paid-up capital of Rs 5.07 M.
The company currently has active open charges totaling ₹10.31 Cr.
Chandra Vaddi and Roopa Putta serve as directors at the Company.
- CIN/LLPIN
U85110TG2011PTC077552
- Company No.
077552
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Nov 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Preeti Urology & Kidney Hospital?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandra Vaddi  | Director | 21-Nov-2011 | Current |
| Roopa Putta | Director | 21-Nov-2011 | Current |
Financial Performance of Preeti Urology & Kidney Hospital.
Preeti Urology & Kidney Hospital Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.2% increase. The company also saw a substantial improvement in profitability, with a 17.35% increase in profit. The company's net worth Soared by an impressive increase of 24.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Preeti Urology & Kidney Hospital?
In 2023, Preeti Urology & Kidney Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Nov 2019 | ₹3.10 M | Open |
Others Creation Date: 31 Oct 2019 | ₹1.24 M | Open |
Others Creation Date: 15 Dec 2016 | ₹8.89 Cr | Open |
How Many Employees Work at Preeti Urology & Kidney Hospital?
Preeti Urology & Kidney Hospital has a workforce of 48 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Preeti Urology & Kidney Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Preeti Urology & Kidney Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
